Avid Bioservices, Inc. (CDMO)

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Kimball Electronics Acquires European-Based Medical CDMO, Helvoet Polymer Technologies B.V.

Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits

Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities

Propanc Biopharma's CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study

Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures

Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives

MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Study with Confirmatory Evidence BLA Filing Strategy for CARTISTEM® in the U.S.

Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients

BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division

Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility

Lifecore Biomedical to Participate at CDMO Live Europe

BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform

Leading CDMO Selects Kneat to Power Digital Validation Transformation